Weight management in a cohort of Irish inpatients with serious mental illness (SMI) using a modular behavioural programme. A preliminary service evaluation

被引:16
作者
Bushe, Chris J. [1 ]
McNamara, Dermot [1 ]
Haley, Cliff [2 ]
McCrossan, Mary Fleming [3 ]
Devitt, Pat [4 ]
机构
[1] Eli Lilly & Co Ltd, Dublin, Ireland
[2] Letterkenny Gen Hosp, Dept Psychiat, Donegal, Ireland
[3] Nursing Dept, Letterkenny, Donegal, Ireland
[4] Adelaide & Meath Hosp, Dept Psychiat, Dublin 24, Ireland
关键词
D O I
10.1186/1471-244X-8-76
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Weight gain is commonly observed during psychotropic treatments for chronic forms of severe mental illness and is most rapid during the early treatment phases. All formats of behavioural weight intervention programmes have suggested that weight gain can be prevented or reversed in some patients. There is no data on these programmes in acutely unwell inpatients whom may be the major beneficiaries. Methods: A modular behavioural intervention programme (Solutions for Wellness) used in SMI outpatients since 2002 in Ireland has been adapted for inpatient use. Preliminary data is reported from 5 centres in Ireland. Results: In 47 inpatients the mean weight change was + 0.26 kg ( SD 2.02) with a median change of 0 kg. Mean follow-up was 23.7 ( SD 21.6) days, and median 14 days (range 6-98 days). There was no difference in mean weight change in those patients involved for > 35 days compared with < 35 days (+ 0.26 kg; 0.25 kg; p = 0.5). Weight loss or maintenance was seen in 70% of patients. Conclusion: These preliminary data are supportive of the concept that acutely unwell inpatients with SMI may engage with a behavioural weight programme. Weight change observed contrasts with the significant weight gain often seen in most subjects. Further clinical trials are warranted.
引用
收藏
页数:5
相关论文
共 28 条
[1]  
ALVAREX M, 2005, SCHIZOPHR B, V21, pS518
[2]   Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder [J].
Brar, JS ;
Ganguli, R ;
Pandina, G ;
Turkoz, I ;
Berry, S ;
Mahmoud, R .
JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (02) :205-212
[3]  
BUSHE C, 25 BIENN C COLL INT
[4]  
Bushe Chris, 2005, J Psychopharmacol, V19, P28, DOI 10.1177/0269881105058682
[5]   Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial [J].
Evans, S ;
Newton, R ;
Higgins, S .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2005, 39 (06) :479-486
[6]   Interventions to reduce weight gain in schizophrenia [J].
Faulkner, G. ;
Cohn, T. ;
Remington, G. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01)
[7]  
GANGULI R, 2005, SCHIZOPHR B, V21, pS561
[8]  
Haddad Peter, 2005, J Psychopharmacol, V19, P16, DOI 10.1177/0269881105058378
[9]   Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: Observational versus randomized studies results [J].
Haro, Josep Maria ;
Suarez, David ;
Novick, Diego ;
Brown, Jacqueline ;
Usall, Judith ;
Naber, Dieter .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (04) :235-244
[10]   Schizophrenia and increased risks of cardiovascular disease [J].
Hennekens, CH ;
Hennekens, AR ;
Hollar, D ;
Casey, DE .
AMERICAN HEART JOURNAL, 2005, 150 (06) :1115-1121